Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of the Pectoral Blocks in the Prosthetic Breast Expansion Surgery
NCT02682186Phase 3Completed
- Sponsor
- CHU Montpellier
- Start
- Feb 2016
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by CHU Montpellier. Primary endpoint: Maximal value of pain intensity according to the numerical scale at 6 hours. Started Feb 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02682186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682186.